Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
26 juil. 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets on...
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
31 mai 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., May 31, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2023 Jefferies Healthcare...
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
09 mai 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2023 RBC Capital Markets Global...
Pacira BioSciences Reports First Quarter 2023 Financial Results
03 mai 2023 08h00 HE
|
Pacira BioSciences
-- EXPAREL continues to outperform elective surgery market with average daily volumes up 6 percent over prior year -- -- Conference call today at 8:30 a.m. ET -- TAMPA, Fla., May 03, 2023 (GLOBE...
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
26 avr. 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on...
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
20 avr. 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla. and IRVING, Texas, April 20, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc., the industry leader in its commitment to non-opioid pain management and regenerative health solutions, and...
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
19 avr. 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
12 avr. 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 22nd Annual Needham Virtual...
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
03 avr. 2023 08h00 HE
|
Pacira BioSciences
– Term Loan A Carries Significantly Lower Interest Rate – – Meaningfully Improves Debt Leverage Ratio and Reaffirms Outlook for Growth -- TAMPA, Fla., April 03, 2023 (GLOBE NEWSWIRE) -- Pacira...
Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures
29 mars 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., March 29, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...